跳至主要内容
临床试验/NCT06269770
NCT06269770招募中4 期

Multimodal Analgesia in TKA. The Role of Tapentadol

University of Thessaly1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2023年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
96
试验地点
1
主要终点
Post-operative pain

研究概览

简要总结

Compare the effectiveness of tapentadol and tramadol as part of a multimodal analgesia treatment for Total Knee Replacement (TKR).

详细描述

As the population ages and becomes more active, the demand for TKR surgery is expected to increase. However, the treatment of TKR pain remains a challenge.

Postoperative pain is associated with longer hospital stays, lower satisfaction, increased opioid consumption, and transition to chronic pain. In TKR, the risk of chronic pain can be as high as 20%.

A suggested method of anesthesia and pain relief is the use of spinal anesthesia along with multimodal analgesia that includes an adductor canal block.

In our hospital, the multimodal analgesia protocol consists of intraoperative sedation with dexmedetomidine, a low dose of ketamine, paracetamol, NSAIDs, and magnesium. Dexamethasone and droperidol are preferred as antiemetics as they can improve the analgesic outcome.

To minimize the use of opioids, the administration of tramadol used to be the standard of care. Tapentadol is an opioid that can be equally effective in the treatment of postoperative pain and reduces the incidence of chronic pain after TKR.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients for elective TKR
  • ASA PS I - III

排除标准

  • Patient refusal
  • Cognitive disfunction
  • Severe psychiatric disease
  • Under medication with MAO inhibitors, tricyclic antidepressants, serotonin reuptake inhibitors
  • Not speaking Greek
  • Known allergy to the study drugs
  • Contraindications for any of the study drugs
  • Chronic renal failure (GFR < 50 ml/h)
  • Liver failure
  • Known regular use or misuse of opioids
  • Pregnant women
  • Patients undergoing general anesthesia

研究组 & 干预措施

Tramadol

Active Comparator

Tramadol will be administered in a multimodal analgesic approach to manage postoperative pain.

干预措施: Tramadol (Drug)

Tapentadol

Active Comparator

Tapentadol will be administered in a multimodal analgesic approach to manage postoperative pain.

干预措施: Tapentadol (Drug)

结局指标

主要结局

Post-operative pain

时间窗: 3rd postoperative day

Visual Analogue Scale (VAS) score measures 0 to 10 (0=no pain, 10=the worst pain)

次要结局

  • Outcome(6 weeks after surgery)
  • Pain severity(6 weeks after surgery)
  • Post-operative pain(6 months after surgery)
  • Patient Satisfaction(5 days after surgery at Discharge)
  • Depression(5 days after surgery at Discharge)
  • Function(6 weeks after surgery)
  • Neuropathic pain(6 months after surgery)
  • Arthritis impact(6 weeks after surgery)
  • Health Status(6 weeks after surgery)
  • Quality of life postoperatively(6 months after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Arnaoutoglou

Professor in Anesthesiology

University of Thessaly

研究点 (1)

Loading locations...

相似试验

Tapentadol vs Tramadol in Total Knee Arthroplasty | 临床试验